An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Patients With Head and Neck Cancer Receiving REGN2810 (Anti-PD-1)

Conditions

• Recurrent Squamous Cell Carcinoma of Head
• Recurrent Squamous Cell Carcinoma of Neck
• Metastatic Squamous Cell Carcinoma of Head
• Metastatic Squamous Cell Carcinoma Neck

Interventions

• DRUG: REGN2810

Sponsor

Regeneron Pharmaceuticals

Collaborators

• [object Object]